VALIDATION OF A PATIENT REPORTED OUTCOME MEASURE (PROM) OF OVARIAN CANCER SYMPTOMS AND TREATMENT RELATED CONCERNS (MOST-OSI) WITH CHEMOTHERAPY IN RECURRENT OVARIAN CANCER (ROC).

被引:0
|
作者
King, M. [1 ]
Stockler, M. [2 ]
O'Connell, R. [2 ]
Joly, F. [3 ]
Lanceley, A. [4 ]
Hilpert, F. [5 ]
Okamoto, A. [6 ]
Aotani, E. [7 ]
Pignata, S. [8 ]
Donnellan, P. [9 ]
Oza, A. [10 ]
Avall-Lundqvist, E. [11 ]
Berek, J. [12 ]
Buizen, L. [2 ]
Sjoquist, K. [2 ]
Butow, P. [1 ]
Friedlander, M. [13 ]
Gillies, K. [2 ]
Martyn, J. [2 ]
机构
[1] Univ Sydney, Psychooncol Res Grp, Sydney, NSW 2006, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[3] Ctr Francoise Baclesse, GINECO, Caen, France
[4] UCL, London, England
[5] Klin Gynakol & Gerburtshilfe, UKSH, Kiel, Germany
[6] Jikei Univ, Sch Med, Tokyo, Japan
[7] Kitisato Acad Res Org, Tokyo, Japan
[8] Natl Canc Inst, Naples, Jamaica
[9] Galway Univ Hosp, Galway, Ireland
[10] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[11] Linkoping Univ, NSGO, Linkoping, Sweden
[12] Stanford Womens Canc Ctr, Stanford, CA USA
[13] Prince Wales Hosp, ANZGOG, GCIG Symptom Benefit StudyGrp GCIG, Kingston, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ESGO-1157
引用
收藏
页码:457 / 458
页数:2
相关论文
共 41 条
  • [41] Patient-reported endocrine symptoms, sexual functioning, and quality of life (QoL) in the IBCSG TEXT and SOFT trials: Adjuvant treatment with exemestane (E) plus ovarian function suppression (OFS) versus tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR plus ) early breast cancer (BC)
    Bernhard, Juerg
    Luo, Weixiu
    Ribi, Karin
    Eon, Marco Col
    Burstein, Harold J.
    Tondini, Carlo
    Pinotti, Graziella
    Spazzapan, Simon
    Ruhstaller, Thomas
    Puglisi, Fabio
    Paves, Lorenzo
    Parmar, Vani
    Regan, Meredith M.
    Pagani, Olivia
    Fleming, Gini F.
    Francis, Prudence A.
    Coates, Alan S.
    Gelber, Richard D.
    Goldhirsch, Aron
    Walley, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)